Chemogenomic Screen for Imipenem Resistance in Gram-Negative Bacteria
ABSTRACT Carbapenem-resistant Gram-negative bacteria are considered a major threat to global health. Imipenem (IMP) is used as a last line of treatment against these pathogens, but its efficacy is diminished by the emergence of resistance. We applied a whole-genome screen in Escherichia coli, Klebsi...
Guardado en:
Autores principales: | Jessica Y. El Khoury, Alexandra Maure, Hélène Gingras, Philippe Leprohon, Marc Ouellette |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a933a8c7d8e94f08abc8a8366fe32f0a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Can Gram-Negative Bacteria Develop Resistance to Antimicrobial Blue Light Treatment?
por: Aleksandra Rapacka-Zdonczyk, et al.
Publicado: (2021) -
OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs
por: Christopher Fröhlich, et al.
Publicado: (2019) -
Susceptibilidad antimicrobiana de cepas de Pseudomonas aeruginosa aisladas en el laboratoriodel Hospital Regional Dr. Leonardo Guzmán de Antofagasta, Chile
por: ZAMBRANO F.,ALCIDES, et al.
Publicado: (2004) -
Caracterización molecular de Escherichia coli y Klebsiella pneumoniae productores de ß-lactamasas de espectro extendido en hospitales de la Región Caribe, Colombia
por: Gaitán C,Sandra L, et al.
Publicado: (2009) -
A New Take on an Old Remedy: Generating Antibodies against Multidrug-Resistant Gram-Negative Bacteria in a Postantibiotic World
por: Michael P. Motley, et al.
Publicado: (2017)